(thirdQuint)BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects.

 Objectives: 1.

 To evaluate the safety and tolerability profile of single oral ascending dose levels of BPN14770 in healthy subjects.

 2.

 To characterize the BPN14770 plasma pharmacokinetic profile following oral administration.

.

 BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects@highlight

This is a randomized double-blind (investigator and subject blinded), placebo controlled ascending single dose study to evaluate the safety, tolerability, and pharmacokinetic profile of BPN14770 in healthy male and female subjects.

 Each subject will be randomized to receive either a single dose of BPN14770 or placebo.

